BWAY Share Price Performance
Recent BWAY News & Updates
No updates
BrainsWay Ltd. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
Aug 13, 2025
- Earnings per share (EPS)
- 0.10
- Gross Margin
- 74.51%
- Net Profit Margin
- 9.01%
- Debt/Equity Ratio
- 0%
BrainsWay Ltd. Competitors
About BWAY
- Founded
- 2003
- Employees
- 120
- CEO
- WebsiteView website
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer’s disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson’s diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
Israeli Market Performance
- 7 Days: -0.5%
- 3 Months: 21.9%
- 1 Year: 64.7%
- Year to Date: 29.5%
Over the last 7 days, the market has remained flat, with no particular sector making any big moves this week. Meanwhile, the market is actually up 65% over the past year. Looking forward, earnings are forecast to grow by 16% annually. Market details ›
Companies across the globe are beginning to pay attention to agentic AI. It’s also a term you’re likely to hear a lot during earnings season. In fact, it came up 26 times during...
Continue reading